PubMed Health⌕ Search

Biomedical subjects

Patrick Rossignol

Publications and source records attributed to Patrick Rossignol.

23 records · Page 2Linked to original sources

[Physiopathology of aortic aneurysm].

Aneurysm is an arterial dilatation with risk of rupture. It is a disease of the media characterized by the destruction of extracellular matrix proteins (especially elastin) involving different proteases: matrix metalloproteinases, fibrinolytic proteases (plasminogen activators, plasmin), leucocyte elastase, and by the absence of scarring process. There is an imbalance in the aortic wall between proteolytic and antiproteolytic activities, the former being overexpressed (by inflammatory cells infiltrating the aortic wall on the adventitial side, and the endoluminal thrombus), the latter (normally synthesized and secreted by vascular smooth muscle cells) being decreased in relation to the disappearance of smooth muscle cells.

Aneurysm, Ruptured↗

Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.

Acquired abdominal aortic aneurysms are usually associated with a mural thrombus through which blood continues to flow. Some early data suggest that aneurysmal evolution correlates with the biological activity of the thrombus. Our hypothesis was therefore that the thrombus could adsorb blood components and store, release, and participate in the activation of proteases involved in aneurysmal evolution. For this purpose, we have explored both the metalloproteinase and fibrinolytic systems in the thrombus and the wall of human aneurysms. We have first investigated blood clot formation and lysis in vitro. Spontaneous clotting induces a release of promatrix metalloproteinase (pro-MMP)-9 into the serum that was fourfold higher than in paired control plasma (P < 0.001). Fibrinolysis progressively released more MMP-9 in a time-dependent manner (P < 0.01). After selective isolation, we demonstrated that polymorphonuclear leukocytes are the main source of MMP-9 release during clot formation. Protease content was then analyzed in 35 mural thrombi and walls of human abdominal aortic aneurysms sampled during surgical repair. In 15 aneurysms, the liquid phase at the interface between the thrombus and the wall was sampled separately. Both thrombus and wall contained MMP-2 and MMP-9 but the ratio MMP-9/MMP-2 was higher in the thrombus than in the wall. The liquid interface also contained active MMP-9. Immunohistochemistry of the thrombus confirmed these findings, showing the presence of polymorphonuclear leukocytes at the luminal pole of the thrombus, co-localizing with MMP-9 storage. In contrast, MMP-3 and MMP-7 were only present in the aneurysmal wall. Plasminogen was present in the mural thrombus but plasmin activity was present in both thrombus and wall. In the liquid interface, plasmin-alpha(2)-anti-plasmin complexes were detected demonstrating in vivo the activation of plasminogen. In contrast, u-PA and t-PA were detectable only in the wall, suggesting that plasminogen present in the thrombus could be activated by factors secreted by the arterial wall. This was demonstrated in vitro, in which co-incubation of thrombus and wall extracts generated plasmin in the presence of a fibrin matrix and activated MMPs. In conclusion, our study strongly suggests that the mural thrombus, by trapping polymorphonuclear leukocytes and adsorbing plasma components could act as a source of proteases in aneurysms that may play a critical role in enlargement and rupture.

Abdominal Wall↗

Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney size.

OBJECTIVES: Angiotensin II, in addition to having vasopressor effects, induces proteinuria in experimental models. Proteinuria has been reported, sometimes in the nephrotic range, in patients with chronic complete renal artery occlusion. We aimed to identify the factors associated with proteinuria in such cases. DESIGN AND MAIN OUTCOME MEASURE: Complete renal artery occlusion was detected by intra-arterial angiography in 96 patients referred for hypertension. We analysed patient characteristics at presentation to identify the factors associated with proteinuria. SETTING: A referral hypertension unit. RESULTS: Median protein excretion was 0.25 g/day (range 0-11). Nine patients had nephrotic syndrome (proteinuria >/= 3.5 g/day per 1.73 m2). Patients in the upper tertile for proteinuria differed from those with lower proteinuria in terms of total cholesterol levels (P < 0.01), the proportion of diabetics (P < 0.01) and supine active renin concentration (P = 0.02). They tended to have higher systolic blood pressure levels (P = 0.07), a lower frequency of contralateral renal artery stenosis (P = 0.09) and a longer contralateral kidney (P = 0.09). In multivariate logistic regression, the factors independently linked to proteinuria in the upper tertile were active renin concentration (P = 0.05) and contralateral kidney length (P = 0.02). Proteinuria significantly decreased in nephrotic patients (P < 0.01) treated with revascularization or nephrectomy and/or angiotensin converting enzyme inhibition. CONCLUSIONS: Proteinuria in renal artery occlusion is positively related to active renin concentration, which reflects plasma angiotensin II concentration. Therapy aimed at lowering angiotensin II levels decreased proteinuria in nephrotic patients. The positive relationship between proteinuria and contralateral kidney length may reflect compensatory hypertrophy in response to nephron function loss.

Adult↗

[Hypertension in the elderly].

Systolic blood pressure rises with age, and the prevalence of hypertension (systolic pressure of 140 mmHg or more and diastolic pressure below 90 mmHg) exceeds 70% after the age of 70. At any age, high systolic pressure is associated with an increased risk of cardiovascular death, stroke and myocardial infarction. Antihypertensive drugs reduce cardiovascular mortality and morbidity in patients with systolic pressure exceeding 160 mmHg. The ability of blood pressure reduction to prevent cardiovascular events in elderly hypertensive patients is often compromised by poor systolic pressure control. This is due to the relatively limited efficacy of antihypertensive medications to normalize systolic blood pressure, but also to the fact that many physicians fail to follow systolic hypertension treatment guidelines.

Adult↗